Unique Case of Malignant Phyllodes Tumor in the Breast Accompanied by Epithelial Carcinoma and Chondrosarcomatous Differentiation - Top-Institutions - MDSpire

Unique Case of Malignant Phyllodes Tumor in the Breast Accompanied by Epithelial Carcinoma and Chondrosarcomatous Differentiation

  • By

  • Jie Yuan

  • Hua Zhang

  • Jun Huang

  • Bei Wang

  • Geng Wang

  • Li Yang

  • April 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Oncology
    • Surgical Oncology
    • Pathology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Surgical Oncology
    • Pathology
    • Medical Oncology

  • #3

    Dana-Farber Cancer Institute / Brigham and Women's Hospital
    Dana-Farber Cancer Institute / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Breast Oncology
    • Pathology
    • Radiology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Breast Surgery
    • Pathology
    • Oncology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Breast Oncology
    • Pathology
    • Surgical Oncology

Original Source(s)

Unique Case of Malignant Phyllodes Tumor in the Breast Accompanied by Epithelial Carcinoma and Chondrosarcomatous Differentiation

  • by Jie Yuan, Hua Zhang, Jun Huang, Bei Wang, Geng Wang, Li Yang

  • April 24, 2026

Related Content

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

Potential targets for boron transport in boron neutron capture therapy